Search Within

Levi Mark Bala Mangarin

Formats
  1. Meeting Abstract (18)
  2. Journal Article (9)
Groups
  1. Department of Medicine (27)
  2. GSK Faculty (27)
  3. Melanoma and Immunotherapeutics Service (27)
  4. Sloan Kettering Institute Postdocs (27)
  5. Solid Tumor Oncology Division (27)
  6. MSK Grad Students (14)

More Groups

People
  1. Jedd Wolchok (27)
  2. Taha Merghoub (27)
  3. Sadna Budhu (16)
  4. Cailian Liu (14)
  5. Roberta Zappasodi (14)
  6. Daniel Hirschhorn Cymerman (10)

More People

Years
  1. 2023 (1)
  2. 2022 (10)
  3. 2021 (5)
  4. 2020 (5)
  5. 2019 (1)
  6. 2018 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (11)
  2. Cancer Research (5)
  3. Journal of Immunology (2)
  4. Cancer Cell (1)
  5. Cancers (1)
  6. Immunity (1)

More Publications

Publishers
  1. Biomed Central Ltd (11)
  2. American Association for Cancer Research (5)
  3. Cell Press (2)
  4. Nature Publishing Group (2)
  5. The American Association of Immunologists, Inc (2)
  6. Amer Soc Clinical Investigation Inc (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • LDH inhibition improves response to CTLA-4 blockade by enhancing effector T cell activity and impairing regulatory T cell suppression
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Mangarin, L.; Ko, M.; Blasberg, R.; Zappasodi, R.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Potential role of CD47 in T cell exhaustion program
    Meeting Abstract

    Weng, C. H.; Samaan, F.; Budhu, S.; Mangarin, L.; Monette, S.; Liu, C.; Pourpe, S.; Hamadene, L.; Zhong, H.; Yang, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Meeting Abstract

    Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Pilot trial of arginine deprivation plus nivolumab and ipilimumab in patients with metastatic uveal melanoma
    Journal Article

    Kraehenbuehl, L.; Holland, A.; Armstrong, E.; O'Shea, S.; Mangarin, L.; Chekalil, S.; Johnston, A.; Bomalaski, J. S.; Erinjeri, J. P.; Barker, C. A.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; HolmstroĢˆm, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save